WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Earnings & Revenue

LYRA past revenue growth

How has LYRA's revenue growth performed historically?
Company
28.74%
Industry
81.78%
Market
19.94%
LYRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LYRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LYRA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LYRA earnings and revenue history

Current Revenue
$1.7M
Current Earnings
-$68.9M
Current Profit Margin
-4,099.8%

LYRA Return on Equity

Current Company
-78.8%
Current Industry
16.8%
Current Market
28.2%
LYRA's Return on Equity (-78.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LYRA announces earnings.

LYRA Return on Assets

Current Company
-51.9%
Current Industry
3.2%
LYRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LYRA Return on Capital Employed

Current Company
-56.04%
Current Industry
-42.4%
LYRA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LYRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LYRA$1.68M-$68.69M-$68.88M+49.37%N/A
GLYC$10.00k-$36.35M-$37.28M-81.74%N/A
LGVN$978.00k-$19.86M-$21.62M-91.75%N/A
ORGS$529.00k-$41.26M-$45.66M-43.95%-83.72%
SNSE$0.00-$29.05M-$31.92MN/AN/A

LYRA earnings dates

Next earnings date
Aug 6, 2024

Lyra Therapeutics Earnings & Revenue FAQ

What were LYRA's earnings last quarter?

On Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q1 2024 earnings per share (EPS) of -$0.35, up 20.45% year over year. Total Lyra Therapeutics earnings for the quarter were -$22.45 million. In the same quarter last year, Lyra Therapeutics's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

What was LYRA's earnings growth in the past year?

As of Q2 2024, Lyra Therapeutics's earnings has grown year over year. Lyra Therapeutics's earnings in the past year totalled -$68.88 million.

What is LYRA's earnings date?

Lyra Therapeutics's earnings date is Invalid Date. Add LYRA to your watchlist to be reminded of LYRA's next earnings announcement.

What was LYRA's revenue last quarter?

On Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q1 2024 revenue of $532.00 thousand up 29.76% year over year. In the same quarter last year, Lyra Therapeutics's revenue was $410.00 thousand.

What was LYRA's revenue growth in the past year?

As of Q2 2024, Lyra Therapeutics's revenue has grown 28.74% year over year. This is 53.05 percentage points lower than the US Biotechnology industry revenue growth rate of 81.78%. Lyra Therapeutics's revenue in the past year totalled $1.68 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.